5 September 2024

Oxford Nanopore Technologies plc

Oxford Nanopore to present at upcoming investor conferences

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore"), the company delivering a new generation of nanopore-based molecular sensing technology, will be presenting at the following investor conferences in September.

·      Goldman Sachs 21st Annual Medtech and Healthcare Services Conference on Thursday, 5 September at 9:00am BST in London, UK

·      BofA Securities Global Healthcare Conference 2024 on Wednesday, 18 September at 1:20pm BST in London, UK

·      Bernstein's 21st Pan European Annual Strategic Decisions Conference on Wednesday, 25 September at 9:00am BST in London, UK

Live webcasts of the events can be accessed at the company's investor relations page at: https://nanoporetech.com/about/investors/reports. Webcast replays will be available for at least 30 days following the events via the same link.

-ENDS-

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:         ir@nanoporetech.com

Media:              media@nanoporetech.com

Teneo (communications adviser to the Company)

Tom Murray, Olivia Peters

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.  Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture.

For more information please visit: www.nanoporetech.com